Three companies, Astex Pharmaceuticals, Eisai Ltd and Eli Lilly and Company, are joining forces with research scientists across Cambridge to explore promising new approaches to the treatment of neurodegenerative disease.
The University provides a wide range of executive education programmes and lifelong learning. Moving all this online during a pandemic has led to the development of a new range of courses for professionals, Cambridge Advance Online.
Wearable technologies will play an important part in the healthcare delivery of the future. Cambridge and Nokia Bell Labs are working together to build the foundations of these transformative technologies.